FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
LIBERTY, Mo., Oct. 18, 2022 -- (Healthcare Sales & Marketing Network) -- Vitti Labs, an AATB Accredited Tissue Bank focused on life science research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has appr... Biopharmaceuticals, FDA Vitti Labs, Polycystic Ovary Syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Marketing | Ovaries | Pharmaceuticals | Polycystic Ovary Syndrome | Science